HELP Helus Pharma

NASDAQ
$7.67

Helus Pharma (HELP) is expected to report earnings on February 12, 2027, before the market open. The consensus earnings estimate is a loss of $0.68 per share.

Helus Pharma Missed Consensus Estimates
Monday, November 16, 2026 · 6:00 AM ET
Earnings Date
3rd Quarter, Dec 2026
Feb 12
Friday · 7:30 AM ET
Earnings Whisper
-
vs ($0.68)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.67

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Helus Pharma

Helus Pharma is a clinical stage pharmaceutical company. Its lead candidate includes HLP003 and HLP004. Helus Pharma, formerly known as Cybin Inc., is based in BOSTON.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.